In celebration of its 35th year, speciality enzyme company, Biocatalysts, has made a major investment into its future manufacturing capacity. Read more


According to scientists from the Medical Research Council (MRC) Laboratory of Molecular Biology in Cambridge, UK, a new drug discovery system can be used to target phosphatases (a family of enzymes) that are mostly considered to be ‘undruggable’. Read more


Researchers from the National Institute of Health (NIH) have identified an enzyme that could help in the fight against mid-life obesity and fitness loss. The findings have been published in Cell Metabolism. Read more


AZD3293 is an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease. Read more

The grant will help fund an examination of the interaction of over 1400 FDA-approved drugs and drug-like compounds with over 30 epigenetic modifying enzymes. Read more

Almac‘s Enzyme Research and Development team has been recognised at The Irish Laboratory Awards by winning 'Laboratory Team of the Year'. Read more